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The RNA polymerase VP1 of IPNV (a bisegmented dsRNA containing virus) is present in the virion both as a free
polypeptide and as a genome-linked protein (VPg). Virion VP1 primes viral RNA synthesis in vitro (P. Dobos, 1995, Virology
208, 19–25), and here we present data which suggest that protein-primed RNA synthesis may also take place in infectious
pancreatic necrosis virus (IPNV)-infected cells. Anti-VP1 serum immunoprecipitated several polypeptides larger than the
94-kDa VP1 of IPNV from [35S]methionine-labeled infected cell lysates. During denaturing, SDS–polyacrylamide gel electro-
phoresis these polypeptides formed a characteristic ‘‘ladder’’ which was resistant to alkaline phosphatase but sensitive to
RNases, indicating that it consisted of VP1 polypeptides with oligoribonucleotides of various lengths attached to them.
Probing the ladder with 59 and 39 end-specific, as well as plus-, or minus-strand-specific oligonucleotides revealed that they
represent VP1 linked to 59 terminal sequences of genome segment A- and B-specific plus strands. Pulse–chase experiments
in combination with two-dimensional polyacrylamide gel electrophoresis revealed that labeled VP1 could be chased to
replicative intermediate, to ssRNA, to dsRNA, and eventually to virion VPg-dsRNA and that VP1 could be released from all
these structures by RNase treatment. We suggest that these results are most compatible with the model where a VP1-pN
structure acts as a primer for viral RNA synthesis in vivo, a mechanism that has been shown to occur in vitro. © 1998 Academic
Press
INTRODUCTION
Infectious pancreatic necrosis virus (IPNV) is the pro-
totype of the family Birnaviridae. It contains a biseg-
mented dsRNA genome which is surrounded by an un-
enveloped, medium-size, icosahedral capsid. The larger
of the two genome segments, segment A (3097 bp),
encodes a 106-kDa polyprotein (NH2-pVP2-NSprotease-
VP3-COOH) which is cotranslationally cleaved by the
viral protease to generate the major capsid polypeptides
VP2 and VP3 (Duncan et al., 1987). The action of the viral
protease cannot be inhibited by supraoptimal tempera-
tures, amino acid analogues, or protease inhibitors, in-
dicating that it may represent a novel class of viral
proteinases (Dobos, 1977; Dougherty and Semler, 1993).
The polyprotein (PP) itself has been detected only re-
cently by Western blotting, both in infected cells and in
purified virus without the use of protease inhibitors, in-
dicating that a small proportion of the PP naturally es-
capes cleavage (Magyar and Dobos, 1994a). (For a re-
cent review on the molecular biology of IPNV see Dobos,
1995). Genome segment A contains an additional small
ORF which overlaps the amino terminal end of the PP
ORF and is in a different reading frame; this small ORF
encodes a 17-kDa arginine-rich minor polypeptide which
can be recovered from infected cell lysates by immuno-
precipitation using anti-17K antiserum (Magyar and Do-
bos, 1994b).
The product of genome segment B (2784 bp) is a minor
internal polypeptide VP1 (94 kDa) the putative virion-
associated RNA-dependent RNA polymerase (RdRp)
(Duncan et al., 1991). This polypeptide is present in the
virion in two forms: (i) as a free polypeptide (VP1) and (ii)
as a genome-linked protein (VPg). In the latter form it is
linked to the 59 end of both genome segments by a
serine–59 GMP phosphodiester bond (Calvert et al.,
1991). This bond can be formed in vitro during the gua-
nylylation of VP1, yielding VP1pG (Dobos, 1993). The
VP1pG complex acts as a primer during in vitro RNA
transcription whereby the plus strands that are synthe-
sized remain base-paired to their respective templates.
This suggests that the VP1-primed in vitro transcription
reaction proceeds via an asymmetric, semiconservative,
strand-displacement mechanism (Dobos, 1995).
In this communication we describe how our attempts
to recover the polyprotein from infected cell lysates led to
the discovery of VP1–oligoribonucleotide complexes in
which the RNA moiety represented 59 terminal se-
quences of plus strands. Part of these complexes could
be chased via replicative intermediates and genome-
length ssRNA to intracellular VP1-dsRNA and finally to
virion VPg-dsRNA. VP1 could be recovered from all of
these intermediates by RNase A treatment. These results
are compatible with the theory that, as in vitro, a VP1pG
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complex may act as a primer for viral plus RNA synthesis
in vivo.
RESULTS
Search for the polyprotein in infected cells
Our original aim was to see if the PP could be recov-
ered from labeled infected cells by immunoprecipitation
in quantities sufficient for subsequent experimentation.
Since the PP is 12 kDa larger than VP1 (94 kDa), we were
looking for a labeled polypeptide that migrated some-
what more slowly than VP1 during PAGE. When infected
cells were labeled with [35S]methionine from 4 to 8 h
postinfection (p.i), a number of polypeptides slightly
larger than VP1 were precipitated by anti-IPNV serum
(Fig. 1A). The same pattern was detected throughout the
infectious cycle using 1-h pulses (data not shown).
Polypeptides larger than VP1 may represent phosphory-
lated forms of VP1, VP1–oligoribonucleotide complexes,
or polyprotein in unphosphorylated, phosphorylated, or
even multiply phosphorylated forms. Glycosylation was
unlikely since the bands were not diffuse and did not
change their electrophoretic mobilities during pulse–
chase experiments (data not shown). We attempted to
characterize these high-molecular-weight polypeptides
by subjecting the immunoprecipitates to various enzy-
matic treatments before PAGE. To increase the resolu-
tion of the gel, 7% polyacrylamide was used and elec-
trophoresis was allowed to proceed until the molecular
size markers reached the bottom of the gel. This way the
VP1 region of the gel (Fig. 1A) could be expanded to a
ladder comprising 8–10 bands (Fig. 1B, lane 1).
Characterization of the ladder
The bands of the ladder were labeled alphabetically
from a to g in order of increasing size, except those of
pp9 and pp, which are thought to represent two forms of
the polyprotein (see below).
Treatment with alkaline phosphatase did not change
the nature of the ladder compared to the untreated con-
trol (lanes 1 and 2). RNase A treatment almost totally
eliminated the ladder; only the two forms of the pp and
molecules that comigrated with band a remained (Fig.
1B, lane 3). The pp9 band in lanes 1 and 2 may represent
two comigrating components; an RNase A-sensitive
component and the polyprotein, since RNase A treat-
ment reduced (but did not eliminate) the intensity of this
band. Treatment with RNase One (which degrades RNA
completely to mononucleotides) eliminated all but the pp
components of the ladder (Fig. 1B, lane 4), the electro-
phoretic migration of which was unaffected by additional
alkaline phosphatase treatment (lane 5). Densitometric
comparison of lanes 1 and 4 indicated that RNase treat-
ment increased the VP1-associated radioactivity from 48
to 89% of the total in this region (data not shown). When
the pp was immunoprecipitated from labeled insect cell
lysates that were infected with recombinant baculovirus
containing IPNV genome segment A cDNA, the two
forms of the pp comigrated with those from infected
CHSE cells (lane 6). Interestingly, in SF cells the pp form
was more abundant than the pp9 form, whereas the
reverse was true in CHSE cells. The upper band was
always sharp and the lower more diffuse, indicating
heterogeneity of the latter. The reason for the two elec-
FIG. 1. Autoradiogram of [35S]methionine-labeled polypeptides immunoprecipitated from IPNV-infected cell lysates by antiviral serum and analyzed
by SDS–PAGE. (A) Infected cells were labeled from 4 to 8 h postinfection and analyzed in a 12% gel; the designations of the virus-specific polypeptides
are indicated on the left. (B) The effect of RNases and alkaline phosphatase on polypeptides larger than VP1. Virus-infected, [35S]methionine-labeled
cell lysates were subjected to immunoprecipitation using anti-IPNV serum or anti-VP1 serum. The precipitates were either untreated (2) or treated
(1) with alkaline phosphatase (AP), RNase A (RA), or RNase One (R1) before SDS–PAGE (7% gel) and autoradiography. Lanes 1–5, 7, and 8 represent
polypeptides immunoprecipitated from CHSE cells, whereas lane 6 represents those from insect (Sf) cells infected with a recombinant baculovirus
expressing the polyprotein ORF of genome segment A of IPNV. To expand the VP1 region, the dye front was allowed to run out of the gel and
electrophoresis was monitored by the position of prestained molecular size markers shown on the right. The radioactive bands in the ladder above
VP1 in lane 1 is arbitrarily labeled from a to g in order of increasing size, except the two RNase-resistant polypeptides pp and pp9, which are thought
to represent two forms of the polyprotein. (C) Autoradiograms of [35S]methionine- and 32P-labeled polypeptides immunoprecipitated from labeled
infected cells by anti-IPNV serum.
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trophoretic forms of the polyprotein is not known and this
question was not pursued further in this study. As ex-
pected, the RNase-sensitive components of the ladder
(but not the polyprotein) were also precipitated by anti-
VP1 serum (lanes 7 and 8). A polypeptide pattern similar
to that of lane 1 was obtained when 32P-labeled infected
cell lysates were analysed and compared to 35S-labeled
bands (Fig. 1C). Taken together these results indicated
that the ladder consisted of VP1 polypeptides complexed
to oligoribonucleotide chains of various lengths which
were resistant to boiling in the presence of SDS and
2-mercaptoethanol; they were collectively designated
VP1(pN)n.
Northern blotting
It was of interest to determine if the VP1(pN)n complex
represented VP1 polypeptides linked to the 59 ends of
plus or minus RNA strands (or both) and if they repre-
sented genome segment A- or B-specific sequences (or
both). To test this, infected cells were labeled with
[35S]methionine between 4 and 8 h p.i., and the viral
polypeptides immunoprecipitated and subjected to
PAGE and electroblotting in four replicates. The blots
were cut to four strips and each was probed with a
different DIG–UTP-labeled oligonucleotide representing
the 59 and 39 ends of the plus and minus strands of
genome segment A as shown in Fig. 2A. Only oligonu-
cleotide 2 (which is equivalent to the 39 end of the minus
strand) hybridized to the VP1 ladder, indicating that the
latter represents VP1 linked to the 59 end of segment
A-specific plus (messenger-sense) RNA (Fig. 2B). After
the chemiluminescence had decayed the blots were
exposed for autoradiography to ascertain that the ladder
from each of the four samples was transferred from the
gel to the nylon membrane (Fig. 2C).
Compared to Fig. 2B, the signal for oligo 2 hybridiza-
tion was weaker at early times (1–4 h p.i) and stronger at
late times (8–12 h p.i.) (data not shown). Repeating the
experiment with segment B-specific oligonucleotides
yielded similar results (data not shown). We could not
detect any minus-strand RNA sequences with either
probe combination regardless of the times (postinfec-
tion) tested.
Resolution of VP1(pN)n complexes to VP1-ssRNA,
VP1-dsRNA, and RIs using gradient SDS–PAGE
If the VP1(pN)n complexes represent in vivo interme-
diates in viral RNA replication, then it should be possible
to recover RIs from infected cell lysates by using anti-VP1
antibodies since nascent RNA chains should have this
polypeptide attached to their 59 ends as a prelude to
their becoming genome linked proteins or VPgs. To this
end 3–9% gradient gels were used where labeled VP1,
VP1(pN)n, VP1-ssRNA, RIs, and VP1-dsRNA could all be
resolved in the same gel if VP1 was allowed to migrate
to the bottom. Care had to be taken to eliminate or inhibit
any contaminating nucleases and proteases after lysing
the infected cells; therefore, the antisera were purified
and RNase and protease inhibitors were included into
the lysis and washing buffers (see Materials and Meth-
ods) and all manipulations were conducted in the cold
using crushed ice.
Infected cells were pulse labeled with [35S]methionine
for 15 min, at which time the medium was replaced with
MEM containing a large excess of unlabeled methionine
and cysteine and the pulse-labeled polypeptides were
‘‘chased’’ for various intervals. At the end of the chase, the
cells were lysed and subjected to imunoprecipitation,
SDS–PAGE, and autoradiography. The data in Fig. 3A
show that anti-VP1 serum precipitated VP1(pN)n com-
plexes containing various lengths of ssRNA (up to full
length, see ladder), RIs, and dsRNA. The intensity of the
ladder and the size of the RI was the largest after a 1-h
chase and became progressively smaller as the length of
the chase increased. These samples were not boiled but
heated only to 60°C to aid solubilization in order not to
denature the RIs. Yet even under these conditions (or as
low as 40°C, data not shown), short VP1-linked nascent
RNA chains became detached from the RIs and migrated
as short VP1(pN)n complexes just above VP1. The longer
VP1(pN)n complexes up to near full-length ssRNA were
more resistant to this treatment and could be detected if
the autoradiograms were overexposed (Fig. 3B).
FIG. 2. Northern blot analysis of the VP1 ladder using segment-
specific, end-specific, and polarity-specific oligonucleotide probes. (A)
Diagram of genome segment A showing the positions of the four
DIG–UTP-tailed oligonucleotide probes used (wavy lines). Oligos 1 and
3 represent the 59 and 39 ends, respectively, of the plus strand; oligos
2 and 4 represent the 39 and 59 ends, respectively, of the minus strand.
(B) Northern blots. [35S]Methionine-labeled polypeptides were immu-
noprecipitated from IPNV-infected cell lysates, analysed by SDS–PAGE,
and electroblotted onto a nitrocellulose membrane which was then cut
into four strips. Each strip was probed by one of the four oligonucleo-
tide probes (lanes 1 to 4). Detection was by chemiluminescence using
a DIG–UTP Ab kit (Boehringer). (C) Autoradiogram of the four blots. The
position of VP1 is shown on the left and those of the molecular size
markers (in kDa) on the right.
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Quantitative pulse–chase experiments
Since VP1 is present in the virion both as a free
polypeptide and in a genome-linked form, one should be
able to chase at least a portion of the radioactive VP1 to
VP1-dsRNA if VP1 becomes VPg during RNA synthesis.
Ideally, a reversible inhibitor of RNA synthesis should be
used during the pulse and removed during the chase.
Unfortunately, no such inhibitor is available. We have
tried guanidine HCl and ribavirin without success. Gua-
nidine HCl, which is a reversible inhibitor of poliovirus
RNA synthesis (Tershak, 1982), did not affect IPNV-spe-
cific RNA synthesis at the concentrations tested (be-
tween 2 and 100 mM; data not shown), whereas ribavirin,
even at high concentrations (400 mg/ml for 4 h) brought
about only a 60% reduction in IPNV-specific RNA synthe-
sis. Consequently, VP1(pN)n complexes formed during
the pulse even in the presence of the inhibitor (data not
shown). We also experimented with shorter pulses with-
out much success. Even when the length of the pulse
was reduced to 5 min, it was not possible to label only
VP1 without there also being some labeled VP1(pN)n as
well. It seems that in those VP1 polypeptides which are
destined to become RNA-linked, the binding of the first
oligoribonucleotides to VP1 occurs as soon as the syn-
thesis of the polypeptide is completed. Therefore we
attempted to demonstrate that some of the small
VP1(pN)n complexes formed during the pulse can be
chased into VP1-dsRNA. The results of such an experi-
ment is shown in Figs. 4 and 5. A 15-min pulse followed
by different chase periods (up to 16 h) is shown in lanes
2–7 of Fig. 4. During the pulse only VP1, short VP1(pN)n
complexes, and a small amount of RI became labeled.
After a 1-h chase the size of VP1(pN)n complexes in-
creased up to full-length VP1-ssRNA, the RI became
more prominent, and VP1-dsRNA also appeared. Be-
tween 2 and 16 h chase the amount of radioactivity in
VP1, the ladder, and the RI diminished, with a temporary
increase (up to 4 h chase) in labeled VP1-dsRNA. Even
visual comparison of lanes 5–7 revealed that the amount
of radioactivity lost from VP1 was not matched by the
radioactivity gained in the VP1-dsRNA band. This was
because by 4 h chase (8 h p.i.) the cells begun to lyse,
FIG. 3. (A) Resolution of VP1, VP1(pN)n, VP1-ssRNA, VP1-dsRNA, and
RI by 3–9% gradient SDS–PAGE. Infected cells were pulse labeled with
[35S]methionine for 15 min at 4 h p.i. followed by incubation in the
presence of a large excess of unlabeled methionine and cysteine for 1,
2, and 5 h. The cells were lysed and the proteins immunoprecipitated
using purified anti-VP1 serum as described under Materials and Meth-
ods. The samples in ESB were incubated in a 60°C water bath for 10
min before loading onto the gel. Electrophoresis was stopped when the
prestained molecular size markers (indicated on the right) reached the
bottom. The gel was then processed for autoradiography. (B) Overex-
posed autoradiogram of a 15-min pulse, 1-h chase sample to show all
the rungs of the ladder between VP1 and VP1-ssRNA.
FIG. 4. Pulse–chase experiment. Uninfected and virus-infected cells
were pulse labeled with [35S]methionine for 15 min at 4 h p.i. followed
by different lengths of chase periods where the cells were incubated in
medium containing a large excess of unlabeled methionine and cys-
teine. Both cell lysates and media were subjected to immunoprecipi-
tation using purified anti-VP1 and anti-IPNV sera and the labeled
polypeptides analysed by 3–9% gradient SDS–PAGE. Electrophoresis
was stopped when the prestained molecular size markers (indicated
on the right) reached the bottom. The gels were fixed, dried, and
subjected to autoradiography. Lane 1, immunoprecipitate from labeled
uninfected cell lysate; lane 2, infected cells, 15-min pulse; lanes 3–7,
infected cells, 15-min pulse followed by increasing lengths of chase
indicated above the lanes; lanes 8–10, immunoprecipitates of the me-
dium after 4, 8, and 16 h chase. Lanes 5–10 represent the combined
precipitates of anti-VP1 and anti-IPNV sera. The positions of RI, VP1-
dsRNA, host-cell-specific bands (asterisks), VP1-ssRNA, and VP1 are
indicated on the left.
FIG. 5. The effect of chase on VP1 and VPg (VPg 5 VP1-dsRNA 1 RI).
Using the autoradiogram of Fig. 4 as template, the radioactive bands
represented by VP1 and VPg (RI 1 VP1-dsRNA) were cut out of each
lane of the dried gel and the radioactivity was counted in a liquid
scintillation counter. (The radioactivity associated with the ladder was
not counted.) The combined counts of VP1 and VPg was considered to
be 100% and the percentage of contribution of each was plotted for
each chase period.
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releasing labeled molecules into the medium both in
soluble form and in the form of assembled virions. The
distribution of radioactivity that was immunoprecipitated
from the medium using anti-VP1 and anti-IPNV sera after
4, 8, and 16 h chase is shown in lanes 8–10.
To quantitate the results, the bands representing VP1
and RI 1 VP1-dsRNA (collectively called VPg) were cut
out of each lane and the amount of radioactivity in each
was measured in a liquid scintillation counter. Where
applicable, the intracellular and extracellular counts
were summed and the results are presented as the
percentage of total radioactivity (Fig. 5). During the 16-h
chase VP1 decreased from 94 to 80%, while VPg in-
creased from 6 to 20%. After the 8- and 16-h chase 16 and
38% of the radioactivity, respectively, were packaged into
virions, while the remaining was found in soluble form in
the cells and the medium (data not shown). Thus virus
morphogenesis appears to be rather inefficient, although
our study followed only those VP1 molecules that were
labeled during the 15-min pulse at 4 h p.i. Latter products
may be packaged more efficiently or virus assembly may
continue beyond the time measured (i.e., 24 h p.i.). The
virion-associated VP1/VPg ratio was 3.2, indicating that
on average each virion contains 12–13 free VP1 mole-
cules and 4 VPgs bound to the ends of the four RNA
strands.
Recovery of VP1 from RIs, VP1-ssRNA, VP1-dsRNA,
and VPg-dsRNA
To show that VP1 can be recovered from the products
of the pulse–chase reaction, labeled components that
were precipitated from infected cell lysates after various
chase times by anti-VP1 serum were analysed in 3–9%
gradient SDS–polyacrylamide gels (as shown in Fig. 4).
After electrophoresis the gel was cut up to individual
lanes and each gel strip was subjected to RNase diges-
tion followed by electrophoresis in the second dimen-
sion using 5% gels (Fig. 6). Panel 1 shows the two-
dimensional autoradiogram of a pulse-labeled sample;
VP1 migrated to the bottom, the ladder and VP1-ssRNA
form a diagonal line, whereas the RI is near the top as it
barely entered the 5% gel. RNase A treatment released
all the RNA-bound VP1 molecules which now migrated to
the bottom of the gel, similarly to free VP1 (panel 3). After
a 1-h chase the amount of labeled VP1 released from
VP1-ssRNA and VP1-dsRNA increased (panel 5). The
autoradiogram of a 4-h chase (without RNase A treat-
ment, panel 2) is similar to that of panel 1 except that
there is little if any RI present. After RNase treatment
(panel 4), VP1 that was associated with large RIs (left
lower corner of panels 3 and 5) are no longer detectable,
the dsRNA-bound VP1 presents a discrete entity and the
amount of VP1 that has migrated with ssRNA and the
ladder has greatly diminished when compared to panel
5. After a 16-h chase most of the RNA-associated VP1
was released from dsRNA (panel 6). The labeled VP1
present in CsCl-purified virus before and after RNase
treatment is shown in panels 7 and 8.
Some of these two-dimensional analyses were re-
peated using 32P-labeled virus (Fig. 7). A 1-h pulse before
and after RNase treatment is shown in panels 1 and 2
and that of purified virus in panels 3 and 4. These results
indicate that the VP1 molecules released by RNase treat-
ment from the various RNA moieties in Fig. 6 were linked
to labeled nucleotides that survived RNase treatment.
The small amount of labeled VP1(pN)n in CsCl-purified
virus (panels 3 and 4 and also Fig. 6, panels 7 and 8) also
represent VP1-59 plus-strand oligonucleotides and are
thought to be the result of abortive transcription during
virus maturation (Kordyban et al., 1997).
DISCUSSION
The presence of VP1(pN)n complexes in IPNV-infected
cells has been demonstrated and the RNase sensitivity
of these complexes indicated that they constitute VP1
polypeptides to which oligoribonucleotides of various
lengths are attached. Northern blot experiments showed
that these oligoribonucleotide sequences represent the
59 ends of the two viral plus RNAs (Fig. 2). The use of
purified antisera, RNase, and protease inhibitors en-
abled us to detect large VP1-RNA complexes containing
up to full-length ssRNA molecules as well as VP1
polypeptides associated with RIs and dsRNA (Fig. 3).
Quantitative pulse–chase experiments revealed that only
20% of the labeled intracellular VP1 became genome-
linked VPg (Figs. 4 and 5). That VP1 can be released from
the various RNA forms by RNase treatment has been
demonstrated by two-dimensional electrophoresis (Fig.
6). Due to the lack of reversible RNA synthesis inhibitors,
we were unable to show that during pulse–chase exper-
iments VP1 can be chased to VP1(pN)n complexes [i.e.,
it was not possible to label only VP1 without there also
being some labeled VP1(pN)n]; however, we did demon-
strate that the VP1-linked oligonucleotides formed during
the pulse could be chased to full-length VP1-ssRNA and
eventually to VPg-dsRNA (Fig. 6). The fact that small
nascent chains (which are derived from replicative inter-
mediates) were precipitated with anti-VP1 antibody
showed that VP1 is linked to the nascent RNA chain at a
very early stage in its synthesis. These short VP1(pN)n
complexes may form either (i) by VP1-primed RNA syn-
thesis where the 59 end nucleotide is covalently linked to
the protein and additional nucleotides are added to this
by the viral RdRp in a template dependent manner or (ii)
by the RdRp-mediated synthesis of short 59 oligonucle-
otides to which VP1 molecules are subsequently linked
to form the VP1(pN)n complexes. We favour the first
alternative for the following reasons: (i) VP1(pN)n could
be chased through RI, VP1-ssRNA to virion VPg-dsRNA
(Fig. 6) and we have shown previously that the 59 end of
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FIG. 6. Two-dimensional electrophoretic analysis of pulse–chase experiments. Infected cells were pulse labeled with [35S]methionine for 15 min
at 4 h p.i. and following various chase times the labeled cell lysates were immunoprecipitated by anti-VP1 serum followed by 3–9% gradient
SDS–PAGE as described under Materials and Methods. The dye front was allowed to run out and electrophoresis was stopped when the two largest
prestained molecular size markers (106 and 80 kDa) reached the bottom of the gel (arrowheads on the right). The gel was cut to individual lanes and
for some the gel strips were soaked in 0.23 SSC containing 100 mg/ml of RNase A (see Materials and Methods), then laid on top of a 5% slab gel,
and subjected to electrophoresis in the second dimension. The gels were then fixed, dried, and placed on X-ray films for autoradiography. All
autoradiograms represent a 15-min pulse followed by various lengths of chase with or without RNase A treatment after the first dimension, as
indicated in the eight panels. Panel 1, 15-min pulse; panel 2, pulse 4-h chase; panel 3, pulse 1 RNase A; panel 4, pulse 4 h-chase 1 RNase A; panel
5, pulse 1-h chase 1 RNase A; panel 6, pulse 16-h chase 1 RNase A; panel 7, pulse, purified virus; and panel 8, pulse, purified virus 1 RNaseA.
Electrophoresis in the first dimension was from left to right and in the second dimension from top to bottom as indicated by the arrows above panels
1 and 2 and on the right of panel 2, respectively. The locations of the origin (Or), dsRNA, ssRNA, and VP1 after the first dimension are indicated at
the top and bottom of the figure. The position of (Or) and VP1 after the second dimension is indicated on the right. () VP1-dsRNA; () VP1-ssRNA.
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the virion RNA is covalently linked to VPg by a serine-59
GMP phosphodiester bond (Calvert et al., 1991); (ii) VP1
primes viral plus-strand RNA synthesis in vitro (Dobos,
1995); (iii) RNase digestion released labeled VP1 from
32P-labeled RI and virion RNA when these were labeled
in vivo (Fig. 7) or VP1pG when labeled in vitro (Dobos,
1995); (iv) protein-primed genome replication has been
shown with a number of viruses such as poliovirus and
adenovirus (Barton et al., 1995; Challberg and Kelly,
1979), and in the case of hepadnaviruses the polymerase
itself serves as a primer for genome replication and
becomes the terminal protein (or VPg) in the process
(Bartenschlager and Schaller, 1988); (v) there is no pre-
cedent for the alternative model whereby VPg polypep-
tides are chemically linked to the 59 ends of preformed
oligonucleotides. Taken together these results strongly
suggest that the VP1-primed RNA synthesis which was
demonstrated in vitro also occurs in vivo.
Although we have shown that VP1 polypeptides are
linked to the 59 ends of plus RNAs, we have no evidence
that these are actually polysome-bound viral mRNAs
since they were not immunoprecipitated from viral poly-
somes. Nevertheless, it brings up the interesting possi-
bility that IPNV plus RNAs may retain their 59-linked VP1
when functioning as messengers. This is in contrast to
poliovirus RNA from which the VPg is removed by a
cellular delinking enzyme before the RNA becomes an
mRNA (Ambrose and Baltimore, 1980). The terminally
linked protein of IPNV is not essential for messenger
activity, since mRNA transcribed from cDNA in vitro or
proteinase K-treated, denatured genomic RNA is faith-
fully translated in a cell-free translation system (Nagy et
al., 1987).
It is intriguing to speculate why some of the VP1
polypeptides become RNA-linked while others remain as
free VP1. Also, what determines whether a VP1 polypep-
tide becomes a primer or functions as an RdRp? It is
possible that the function of a given VP1 polypeptide is
determined by the extent of its phosphorylation. This
kind of control has been demonstrated with vesicular
stomatitis virus and human parainfluenza virus where
phosphorylation of the P protein (by cellular kinases) is
essential for their transcriptional activity (Barik and Ban-
erjee, 1992; De et al., 1995).
MATERIALS AND METHODS
Virus, cells, and antisera
The Jasper strain of IPNV was grown at 20°C in CHSE
cell monolayers in minimum essential medium (MEM)
containing 5% fetal calf serum and the virus was purified
by polyethylene glycol precipitation, freon extraction, and
FIG. 7. Two-dimensional electrophoretic analysis of immunoprecipitates of infected, 32P-labeled cell lysates and 32P-labeled purified virus. Infected,
actinomycin D-treated cells were labeled with [32P]orthophosphoric acid for 1 h at 6 h p.i. The cells were lysed and immunoprecipitated with anti-VP1
serum followed by two-dimensional PAGE as described for Fig. 6. Similarly, 32P-labeled purified virus was also analysed before and after RNase A
treatment. Panel 1, immunoprecipitate of cell lysate; panel 2, immunoprecipitate of cell lysate after RNase A treatment; panel 3, purified virus; panel
4, purified virus after RNase A treatment.
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sucrose and CsCl density gradient centrifugation as de-
scribed previously (Dobos and Rowe, 1977). The con-
struction of recombinant baculovirus AcPP containing
the polyprotein ORF of IPNV and its growth in Spodopt-
era frugiperda (Sf21) cells have been described recently
(Magyar and Dobos, 1994a). Rabbit anti-IPNV or anti-VP1
serum was purified and concentrated by passing it
through a column containing DEAE–Affi-Gel Blue (Bio-
Rad), the flowthrough was placed into a dialysis bag, and
the antiserum concentrated fourfold by covering the bag
with polyethylene glycol 8000 powder followed by dialy-
sis against 10 mM Tris–HCl, pH 8.0. This procedure was
to remove the albumin and most of the serum protease
and RNase activity (Crawford and Baltimore, 1983).
Radiolabeling of infected cells and
immunoprecipitation
Confluent cell monolayers in 35-mm tissue culture
plates were infected with three times plaque-purified
virus at a multiplicity of infection of 10. At various times
postinfection the medium was replaced with methionine-
and cysteine-free medium containing 100 mCi/ml of
TRANS LABEL [35S]methionine and [35S]cysteine (ICN,
sp act .1000 Ci/mmol) and the cultures were incubated
for various intervals. At the end of the labeling period the
medium was removed, the monolayers were washed
with phosphate-buffered saline (pH 7.4), and the cells
lysed as described by Jackson et al. (1995). Briefly, the
cells were disrupted in lysis buffer I (150 mM NaCl, 50
mM Tris–HCl, pH 8.0, 0.6% NP-40) containing 1.6 mg/ml
of a protease inhibitor cocktail (Complete; Boehringer
and Mannheim) and 100 units/ml of the RNase inhibitor
RNaseOut (Boehringer). The nuclei were removed by
low-speed centrifugation and to the supernatant an
equal volume of lysis buffer II was added (150 mM NaCl,
50 mM Tris–HCl, pH 8.0, 1.4% NP-40, 2% deoxycholate,
and 0.2% SDS). The virus-specific labeled polypeptides
were recovered by immunoprecipitation using anti-IPNV
or anti-VP1 serum and a suspension of Formalin-fixed
Staphylococcus aureus (Calbiochem) followed by wash-
ing as described previously (Magyar and Dobos, 1994b).
The final immunoprecipitates were resuspended in 23
electrophoresis sample buffer (ESB) (13 ESB: 0.0625 M
Tris–HCl, pH 6.8, 1% SDS, 2% b-mercaptoethanol, 10%
glycerol, and a trace of bromphenol blue) followed by
heating in a 60 or 100°C water bath for 10 min. The
samples were centrifuged at 12,000 g for 10 min to
remove the staphylococci before SDS–polyacrylamide
gel electrophoresis (SDS–PAGE).
To label virus RNA with 32P, 0.5 mg/ml of actinomycin D
was added to infected cells at 3 h p.i. At 6 h p.i. the
medium was replaced with phosphate-free MEM to
which [32P]orthophosphate was added (0.5 mCi/ml ICN)
and incubation continued for 1 h. At this time the cells
were lysed and processed for immunoprecipitation as
described above for the [35S]methionine-labeled cul-
tures. 32P-labeled purified virus was produced as de-
scribed recently (Kordyban et al., 1997).
Nuclease and phosphatase treatment of
immunoprecipitates
Before PAGE the immunoprecipitates were resus-
pended in 10 ml of 10 mM Tris–HCl, pH 8.0, and treated
as follows: RNase A at a concentration of 100 mg/ml in
the presence of 10 mM MgCl2; RNase ONE (Promega) at
a concentration of 100 U/ml in the presence of 10 mM
Tris–HCl (pH 7.5), 5 mM EDTA, 200 mM sodium acetate;
(this is the only RNase that degrades RNA completely to
mononucleotides); calf intestinal alkaline phosphatase
(CIAP) at a final concentration of 140 U/ml in the pres-
ence of 10 mM Tris–acetate, 10 mM MgAc, 50 mM KAc.
All samples were incubated for 1 h in a 37°C water bath.
Digestions were stopped by adding an equal volume of
23 ESB to each sample.
One- and two-dimensional polyacrylamide gel
electrophoresis and autoradiography
SDS–PAGE using 7, 10, or 3–9% gradient gels was
performed as described by Laemmli (1970). Prestained
molecular size markers (low range) were purchased from
Bio-Rad. For two-dimensional gel electrophoresis sam-
ples were analysed first using 3–9% gradient slab gels
with the inclusion of prestained molecular size markers
in each lane. Electrophoresis was stopped when the two
largest markers (106 and 80 kDa) reached the bottom of
the gel. The gel was cut up to individual lanes which
were either untreated or treated with RNase A as follows.
The gel strips were soaked in 0.23 SSC (13 SSC: 150
mM NaCl, 15 mM Na citrate) containing 100 mg/ml of
RNase A at 37°C for 30 min, then equilibrated in stacking
gel buffer for 15 min, and each gel strip was placed on
top of a 5% SDS–slab gel and subjected to electrophore-
sis in the second dimension until the prestained molec-
ular size markers reached the bottom. The gels were
then fixed, soaked in Amplify (Amersham) for 20 min,
dried, and placed onto KODAK X-OMAT AR X-ray film for
autoradiography.
39 tailing of oligonucleotide probes
The following genome segment-specific, end-specific,
and polarity-specific oligonucleotides (20-mer) were
used: oligo 1 (A 1 5) 59-GGAAAGAGAGTTTCAACGTT-39;
oligo 2 (A 2 3) 59-AACGTTGAAACTCTCTTTCC-39; oligo 3
(A 1 3) 59-CCGGCCCCCCAGGGGGCCC39; oligo 4 (A 2
5) 59-GGGGCCCCCTGGGGGGCCGG-39.
The tailing of oligonucleotides at the 39 end with DIG-
11–dUTP and terminal transferase was according to the
manufacturer’s specification (DIG Oligonucleotide tailing
kit; Boehringer Mannheim).
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Northern blotting
[35S]Methionine-labeled, immunoprecipitated, virus-
specific polypeptides in four replicates were analysed by
SDS–PAGE (7% gel) followed by electroblotting onto Ny-
tran1 (Schleicher & Schuell) in 13 TBE, pH 8.0, at 80 V
for 80 min. The blots were allowed to air dry overnight
and then baked at 80°C for 90 min and cut into four
strips. Prehybridization was in standard buffer (53 SSC,
0.1% sodium lauroylsarcosine, 0.02% SDS, 1% blocking
reagent; Boehringer Mannheim). Hybridization at an oli-
gonucleotide concentration of 2 pmol/ml, also in stan-
dard buffer, was overnight at 45°C for oligos 1 and 2 and
at 75°C for oligos 3 and 4. The DIG-11–dUTP-labeled
oligonucleotides were detected with the DIG Lumines-
cent Detection Kit for Nucleic Acids (Boehringer Mann-
heim). Exposure to X-ray film was for 2 min. Thereafter,
the chemiluminescence was allowed to decay for 5 days,
when the blots were placed on X-ray films for autora-
diography (3 days).
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